Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
about
Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndromeUpdate and new approaches in the treatment of Castleman diseaseRadiotherapy of unicentric mediastinal Castleman's diseaseCastleman's disease: from basic mechanisms to molecular therapeuticsSuccessful treatment of multicentric Castleman's disease accompanying myeloma with bortezomibHow I treat POEMS syndromeCoexistence of Hodgkin's Lymphoma and Castleman's Disease: A Case Report with Successful Response to Chemotherapy and Radiotherapy.POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature.New advances in the diagnosis and treatment of POEMS syndrome.Multicentric Castleman's disease: a challenging diagnosis.Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.Siltuximab for multicentric Castleman disease.HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.Efficacy of bortezomib and thalidomide in the recrudescent form of multicentric mixed-type Castleman's disease.Use of a claims database to characterize and estimate the incidence rate for Castleman disease.Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.TAFRO syndrome: current perspectives.Biologic Agents in the Treatment of Multicentric Castleman Disease
P2860
Q24202634-33F06053-DB73-45AF-A5BC-7A72C9541731Q26740703-AD92E900-5DE0-46C2-B47F-04F123D08E02Q33579669-2097170E-C34D-4348-BDED-27EC37FAF09AQ35584575-8889C255-49FB-45BE-866B-E7C32CBB837AQ35979274-30AF1A8F-8192-422D-B9C5-2B3770E35FC0Q36181433-D3AF2C2A-33D9-4922-949B-3FA8BFB77949Q37408163-4D931A34-D72D-4656-A4CA-476C4E58B0A7Q37890982-46090E81-DE04-42E1-BB97-0CF26DFC4B4CQ38061553-5DEBEF1F-3736-41B9-988E-7CDF2C0A0829Q38080588-A456ECF0-AC44-497C-8D9C-79089E34A3E6Q38091671-181FC5A6-2D7D-4887-9478-4ACEBE1B2950Q38167836-2B0A3606-9028-4093-9245-EBDF750E589AQ39146671-A22B8908-F998-4AE8-A6A0-795FBFBC6994Q43065583-082F11D1-1A20-4EE4-A198-26B37F005719Q43213062-F5642FA6-07E3-4C6F-9817-2B26685791FEQ43956973-8AF04EF4-35C2-4B3F-BFE5-2695493DCA04Q45747998-950525AA-A0A8-43D5-BFB4-ABE90C8F09BFQ49384282-DB44BF32-F1C3-4CEC-B08C-981EF5A335D2Q59137206-EFFB9126-FF03-445D-980F-A0B62E7F8C84
P2860
Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Efficacy of bortezomib in refr ...... syndrome (MCD-POEMS variant).
@en
Efficacy of bortezomib in refr ...... e associated to poems syndrome
@nl
type
label
Efficacy of bortezomib in refr ...... syndrome (MCD-POEMS variant).
@en
Efficacy of bortezomib in refr ...... e associated to poems syndrome
@nl
prefLabel
Efficacy of bortezomib in refr ...... syndrome (MCD-POEMS variant).
@en
Efficacy of bortezomib in refr ...... e associated to poems syndrome
@nl
P2093
P1433
P1476
Efficacy of bortezomib in refr ...... syndrome (MCD-POEMS variant).
@en
P2093
Angeles Bendaña Lopez
Jose Diaz Arias
Jose Luis Bello Lopez
Marta Anna Sobas
Maximo Fraga Rodriguez
Natalia Alonso Vence
P304
P356
10.1007/S00277-009-0795-6
P577
2009-07-28T00:00:00Z